100XBIO

100XBIO

United StatesUnited States
•Pre-Seed•Founded 2023•Updated 1 month ago
Bio Tech/Life SciencesRobotics and dronesAI/MLHealthtechDeep TechB2B1-5 employees
Actively RaisingSerial EntrepreneurSerial Entrepreneur

About

100XBIO builds autonomous robots that automate cell biology R&D. We transform complex, multi-day experiments into one-click operations using a patented benchtop system that is 10x more affordable than legacy automation. By deploying this across hundreds of labs, we are building a network of standardized, machine-ready data—the essential physical layer for AI-driven biology.

Traction & Metrics

Users & Clients

0

Users

3

Clients

Fundraising

$335K

Previous Round

Team

Sergei

Sergei

CEO

Timofei

Timofei

CTO

Products

Hybrid Cytometry Platform

Automated benchtop robot that combines microscopy and cytometry for cell biology R&D. Automates 2-day experiments with imaging and cytometry including cell treatment, staining, and analysis in 1-click operation. Covers over 80% of standard protocols used in over 90% of Cell and Cancer Biology labs. Features live-cell tracking, high multiplexity, data-rich imaging, 10X cheaper scaling, live-to-fixed data capabilities, and minimal cell losses. In some applications enables 10-100x more tests per biosample through repeated data reads using patented technology. Reduces setup costs by 10x compared to traditional $1M-$3M room-sized systems, with first two years costing just $80K upfront.

Click to read more